4//SEC Filing
McGinnis Christopher A 4
Accession 0001809519-25-000046
CIK 0001809519other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:47 PM ET
Size
7.9 KB
Accession
0001809519-25-000046
Insider Transaction Report
Form 4
McGinnis Christopher A
See Remarks
Transactions
- Award
Restricted Stock Unit
2025-03-03+716,479→ 716,479 total→ Class A Common Stock (716,479 underlying) - Award
Stock Option (Right to Buy)
2025-03-03+1,096,937→ 1,096,937 totalExercise: $4.85Exp: 2035-03-03→ Class A Common Stock (1,096,937 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
- [F3]The option will vest and become exercisable as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001652479
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:47 PM ET
- Size
- 7.9 KB